SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (21223)4/23/1999 4:25:00 AM
From: 777 Captain  Read Replies (1) | Respond to of 23519
 
VLAD: maybe that explains why VVUS is up overseas. Unless my quote is wrong, VVUS is up .80 Euro's at this hour. It's at $ 5.12/share US. Volume is lousy (never see much volume in Germany.) There appears to be more here than meets the eye. We'll see what tomorrow brings. Regards.



To: VLAD who wrote (21223)4/23/1999 7:05:00 AM
From: DaiS  Read Replies (2) | Respond to of 23519
 
Vlad, OK I spoke to Zeneca IR in London...I have a name....so I can go back.....
The conversation yielded little and confirmed what I posted yesterday got from Astra....
Message 9088647

Integration is in early stages...launch delays are not anticipated...and for timebeing we should refer to Astra IR for further information.

Remember it might take me long time to cutlivate trust sufficient to get snippets of info like...

<Vivus was fairly sure that they had a deal in the bag for a domestic partner with AZ. The main person Vivus was negotiating with at Astra before the merger had given the green light for the deal. Then this merger crap creates some undesired turmoil. Evidently the higher up of the Astra negotiator is a Zeneca man. And due to egos and a still in process jockeying for power struggle the Zeneca man decided to flex his ego and not give approval for the deal. Can't blame Lee for that.>

Zeneca man could not surely have been involved in the negotiations because they must have taken place largely before the merger was formalised...so it means simply that a Zeneca high up put a red light AFTER the merger...how could he put a red light before the merger...

Leland said earlier that Vivus had strong interest from a company undergoing restructuring and that this company (Astra) could make an improved offer once the internal turmoil was resolved and Vivus was patient to wait a little longer.....so was the good deal this improved offer..made before the merger....actually I don't understand what is going on something does not square somewhere..... but does not seem too promising to me...

Regarding the PE, I remember reading that ice and anaesthetics have been used in past so it was not clear to me why Ed suggested transurethral therapy no good approach....maybe he change his mind now???

DaiS